Skip to main navigation
Skip to search
Skip to main content
UK Health Security Agency Main
Search content at UK Health Security Agency
Main
Profiles
Research units
Projects
Research output
Prizes
Activities
Impacts
An evaluation of emerging vaccines for childhood meningococcal disease
Debajeet Choudhuri
, Tanvir Huda
, Evropi Theodoratou
, Harish Nair
, Lina Zgaga
, Rachel Falconer
, Ivana Luksic
, Hope L. Johnson
, Jian Shayne F. Zhang
, Shams El Arifeen
, Christopher B. Nelson
,
Ray Borrow
, Harry Campbell
, Igor Rudan
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'An evaluation of emerging vaccines for childhood meningococcal disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Meningococcal Vaccine
100%
Meningococcal Disease
100%
Meningitis
100%
Serogroup A
75%
Meningococcal Conjugate Vaccine
75%
CHNRI
75%
Conjugate Vaccine
50%
Disease Burden
50%
Africa
50%
Serogroup W
50%
Meningococcal Meningitis
50%
Multivalent
50%
Potential Impact
25%
Serogroup C
25%
Neisseria Meningitidis
25%
Herd Immunity
25%
Healthcare Workers
25%
Young children
25%
Expert Opinion
25%
Cause of Disease
25%
Health Researchers
25%
Politicians
25%
Sub-Saharan Africa
25%
Meningococcal Polysaccharide Vaccine
25%
Major Outbreak
25%
Children under 5 Years
25%
Meningitis Belt
25%
Monovalent Cations
25%
Global Public Health
25%
Meningitidis
25%
Infant Patients
25%
African Countries
25%
International Policy
25%
Emergency Department Use
25%
Limited Ability
25%
Health Research
25%
Setting Priorities
25%
Implementation Cost
25%
Deliverability
25%
Pharmaceutical Companies
25%
Research Investment
25%
Answerability
25%
Product Cost
25%
Mutual Optimism
25%
Development Cost
25%
Cost Criterion
25%
Structured Assessment
25%
Adequate Immune Response
25%
Priorities in Health
25%
Basic Scientist
25%
Medicine and Dentistry
Meningitis
100%
Meningococcal Disease
100%
Conjugate Vaccine
100%
Meningococcus Vaccine
80%
Health Care Cost
60%
Serotype
60%
Disease Burden
40%
Epidemic Meningitis
40%
Diseases
40%
Public Health
20%
Herd Immunity
20%
Immune Response
20%
Pathogen
20%
Polysaccharide Vaccine
20%
Neisseria meningitidis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Conjugate Vaccine
100%
Meningococcosis
100%
Meningitis
100%
Meningococcus Vaccine
80%
Diseases
80%
Epidemic Meningitis
40%
Infectious Agent
20%
Neisseria meningitidis
20%
Polysaccharide Vaccine
20%
Immunology and Microbiology
Meningitis
100%
Conjugate Vaccine
71%
Meningococcal Vaccine
57%
Serotype
42%
Disease Burden
28%
Immune Response
14%
Neisseria meningitidis
14%
Infectious Agent
14%
Polysaccharide Vaccine
14%
Herd Immunity
14%